PV

Pajir Vishwanath Rajesh Rai

Active Director Nominee Director DIN 03284892
DIN 03284892 First appointment Nov 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 9 historical roles
Total affiliations 10 Since Nov 2010
Shareholding value •••• Premium profile

About Pajir Vishwanath Rajesh Rai

Data last updated:

Pajir Vishwanath Rajesh Rai is a Nominee Director at Remidio Innovative Solutions Private Limited (since 2018). The companies operate in Healthcare, Electrical and Life Sciences. Remidio Innovative Solutions Private Limited reported revenue of ₹55.31 Cr (FY 2025). Earlier, Pajir Vishwanath Rajesh Rai was a Director at Sedemac Mechatronics Limited (2011–2017) and Director at Consure Medical Private Limited (2012–2017) and 7 more.

DIN 03284892
Primary Designation Nominee Director
Industry Healthcare
First Appointment 22 Nov 2010
Oldest Company Age 16 yrs
Largest company Remidio Innovative Solutions Private Limited · ₹55.31 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director30 May 20182009₹55.31 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sedemac Mechatronics Limited U29253PN2007PLC246956
Director06 Sep 20112007₹663 Cr (FY 2025)Active
Consure Medical Private Limited U33112GJ2011PTC067964
Director07 Aug 20122011₹9,500 (FY 2024)Under Liquidation
Director21 May 20122010₹11.19 Cr (FY 2025)Active
Iken Solutions Private Limited U72200MH2005PTC155074
Director17 May 20162005₹1.83 Cr (FY 2024)Active
Mitra Biotech Private Limited U73100KA2009PTC051875
Additional Director22 Nov 20102009₹1.36 Cr (FY 2016)Dissolved (Liquidated)
Vegayan Systems Private Limited U72200MH2005PTC157495
Director07 Mar 20162005₹10.41 Cr (FY 2025)Active
United Mobile Apps Private Limited U72900TN2009PTC073455
Additional Director21 Mar 20122009Active
Director13 Mar 20122012₹1.58 Cr (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Pajir Vishwanath Rajesh Rai

Directorship timeline

Open interactive timeline →
Remidio Innovative Solutions Private Limited
Sedemac Mechatronics Limited
Consure Medical Private Limited
Shantani Proteome Analytics Private Limited
Premium access

Shareholding and investment profile for Pajir Vishwanath Rajesh Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pajir Vishwanath Rajesh Rai

Pajir Vishwanath Rajesh Rai currently holds 1 directorship: Remidio Innovative Solutions Private Limited (Nominee Director, since 30 May 2018, revenue ₹55.31 Cr (FY 2025)).

Pajir Vishwanath Rajesh Rai was first appointed on 22 Nov 2010 as Additional Director at Mitra Biotech Private Limited. The most recent appointment on record is 30 May 2018 at Remidio Innovative Solutions Private Limited.

Pajir Vishwanath Rajesh Rai held 9 earlier board appointments: Sedemac Mechatronics Limited (Director, 06 Sep 2011 to 14 Jun 2017); Consure Medical Private Limited (Director, 07 Aug 2012 to 27 Jun 2017); Shantani Proteome Analytics Private Limited (Director, 21 May 2012 to 28 Jun 2017); Iken Solutions Private Limited (Director, 17 May 2016 to 30 Jul 2018); Mitra Biotech Private Limited (Additional Director, 22 Nov 2010 to 19 Dec 2016); and 4 more.

The current boards of Pajir Vishwanath Rajesh Rai's companies include Anand Sivaraman (Remidio Innovative Solutions Private Limited), Wilson Dsouza (Remidio Innovative Solutions Private Limited), Ziyu Wang (Remidio Innovative Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available